Search
Ferric oxyhydroxide
go.drugbank.com/drugs/DB14695ExperimentalAn antiferromagnetic material; constitutes the core of natural ferritin.
IK-930
go.drugbank.com/drugs/DB18149InvestigationalIK-930 is an oral, paralog-selective TEAD inhibitor.
RO-5028442
go.drugbank.com/drugs/DB12721InvestigationalRO5028442 has been used in trials studying Autistic Disorder.
ACT-451840
go.drugbank.com/drugs/DB13054InvestigationalACT-451840 has been used in trials studying Malaria.
Plamotamab
go.drugbank.com/drugs/DB18944InvestigationalPlamotamab is under investigation in clinical trial NCT05328102 (Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (
161Tb-PSMA-1
go.drugbank.com/drugs/DB33964Experimental161Tb-PSMA-1 is a small molecule drug. 161Tb-PSMA-1 is under investigation in clinical trial NCT07828249 (Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal
SYNB1891
go.drugbank.com/drugs/DB17541Investigational[A256733] SYNB1891 is under investigation in clinical trial NCT04167137 (Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Subjects).
Gamcemetinib
go.drugbank.com/drugs/DB21624InvestigationalGamcemetinib is under investigation in clinical trial NCT04947579 (A Study of CC-99677 in Participants With Active Ankylosing Spondylitis). … The usage of the INN stem '-tinib' in the name indicates that Gamcemetinib is a tyrosine kinase inhibitor.
WX-554
go.drugbank.com/drugs/DB21749InvestigationalWX-554 is under investigation in clinical trial NCT01581060 (Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours).
Urolithin A
go.drugbank.com/drugs/DB15464ExperimentalIt has been demonstrated to stimulate mitophagy and improve muscle health in old animals and in preclinical models of aging.[A179494]